Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological or cytological documentation of adenocarcinoma of the colon or rectum.
At least 1 measurable lesion as per RECIST
ECOG Performance Status of 0 - 1
Life expectancy of at least 12 weeks.
Adequate bone marrow, liver, and renal function
You may not be if
More than 1 previous chemotherapy for Colorectal Cancer. Adjuvant chemotherapy for Colorectal Cancer (Stage I, II, II) is permitted, if the adjuvant therapy ended \>6 month before screening.
Previous FOLFOX treatment for patients who will be included in the mFOLFOX6 cohort apart from FOLFOX treatment in an adjuvant setting.
Previous FOLFIRI treatment for patients who will be included in the FOLFIRI cohort.
Clareo Health | Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI
